Company Essex Bio-Technology Limited Deutsche Boerse AG
Equities
EB51
KYG312371035
Pharmaceuticals
Business Summary
Number of employees: 1,481
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Surgical
55.9
%
| 764 | 58.0 % | 953 | 55.9 % | +24.73% |
Ophthalmology
44.1
%
| 554 | 42.0 % | 753 | 44.1 % | +36.10% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1,318 | 100.0 % | 1,707 | 100.0 % | +29.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 00-07-30 |
Qi Xue
CTO | Chief Tech/Sci/R&D Officer | 63 | 18-04-08 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 14-12-31 |
Lai Man Yau
BRD | Director/Board Member | 60 | 00-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mia Je Ngiam
FOU | Founder | 70 | 99-01-31 |
Lai Man Yau
BRD | Director/Board Member | 60 | 00-12-31 |
Mee Mooi Yeow
BRD | Director/Board Member | 72 | 04-09-29 |
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 00-07-30 |
Chi Ying Fung
BRD | Director/Board Member | 69 | 01-06-12 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 14-12-31 |
Man Sing Yan
BRD | Director/Board Member | 66 | 23-06-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 567,540,000 | 260,911,033 ( 45.97 %) | 0 | 45.97 % |
Company contact information
Essex Bio-Technology Ltd.
West Tower, Shun Tak Centre 168-200 Connaught Road
, Hong Kong
+
http://www.essexbio.com![address Essex Bio-Technology Limited(EB51)](https://cdn.zonebourse.com/static/address/451139.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.96% | 101B | |
+8.29% | 42.63B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B | |
-55.52% | 8.98B |